anthonyyazdaniml/gliner-biomed-curated-corpus huggingface dataset:
PROBLEM TO BE SOLVED: To provide a safe detergent composition containing a coloring component, having high cleansing effect, capable of coloring, and capable of confirming whether rinsing is perfectly carried out in order to solve a problem on food sanitation caused by polluted hands. SOLUTION: This detergent composition comprises a PH indicator, in which the liquid property is colorless or pale in the vicinity of neutrality, clearly exhibiting color in acidity or alkalinity as a coloring component. This cleansing composition is obtained by previously impregnating a solution of an acidic or alkaline substance therein. It is most effective to completely wash stain away in order to prevent hands from bacterial pollution. When washing and rinsing are imperfect after using the detergent, remaining PH indicator is colored by an acid or an alkali in the cleansing material. As a result, users can conform the imperfect washing and rinsing and trouble on food sanitation can beforehand be prevented.
A polydopamine hair dye comprises dopamine, leucine hydroxylase and transition metal chelator. The dopamine is self-assembled into nano particles under the action of the tyrosine hydroxylase and the transition metal chelating agent, and the nano particles can be adsorbed on the hair surface. The weight ratio of the dopamine to the tyrosine hydroxylase to the transition metal chelator is (20-10): 0.8-0.2): 3-0.15. The transition metal chelating agent is one or more of copper ions, ferrous ions and iron ions. The invention also discloses a preparation method of the polydopamine hair dye. The hair dye provided by the invention is a natural molecule, and has good dyeing ability and biocompatibility. Compared with other commercial hair dyes and other polydopamine dyeing methods, under the same environmental condition, the invention has the advantages of higher hair dyeing speed and less environmental pollution, is safe, effective and convenient to use, can be used for family hair dyeing scenes, and has good practical value.
The present invention relates to Cupriavidus sp. bacterium-derived nanovesicles and to a use thereof. The present inventors have experimentally found that levels of the vesicles are significantly reduced in samples from patients with: malignant diseases such as stomach cancer, colon cancer, pancreatic cancer, cholangiocarcinoma, breast cancer, ovarian cancer, bladder cancer, prostate cancer, head and neck cancer, lymphoma, etc.; cardiac diseases such as cardiomyopathy, atrial fibrillation, variant angina, etc.; chronic obstructive pulmonary disease; stroke; diabetes; renal insufficiency; dementia; Parkinson′s disease; depression, and the like compared to normal persons. Also, the vesicles significantly inhibit the pathogenic vesicle-induced secretion of inflammation mediators as well as suppress oncogenesis.
This arm will determine if blockade of the renin-angiotensin system reduces myocardial fat levels and improves insulin sensitivity. It consists of 6 visits: visit1 (baseline); visit2 (2 weeks); visit3 (1 month); visit4 (3 month); visit5 (6 month); visit6 (8 month). Visits 1 \& 6 will consist of blood tests, glucose tolerance test by FSivGTT, MRS, \& 24 hr ambulatory blood pressure monitoring. During visit 1, patients receive automatic blood pressure monitor, OMRON, to record blood pressure between visits. Visits 2 \& 3 are needed for the adjustment of medication to the final dose level. During visits 4 \& 5, Dr. Price will check subject's status as they continue the medication. In case of uncontrolled blood pressure, Dr. Price will prescribe amlodipine for the additional BP control.
PURPOSE: The purpose of this study was to examine the influence of socioeconomic deprivation on language and developmental outcomes in toddlers with cleft palate with or without cleft lip (CP ± L). Other factors known to influence language outcomes were also considered, including home language history, history of hearing problems, syndromic diagnoses, and sex.
METHOD: A multicenter, cross-sectional study design was conducted. Data for 566 16-month-old toddlers with CP ± L were collected from 17 outpatient cleft palate clinics located throughout the United States. Outcome measures included the MacArthur-Bates Communicative Development Inventories, LENA Developmental Snapshot, age at first word as reported by the caregiver, and the Ages and Stages Questionnaires-Third Edition (ASQ-3). Multivariable linear or logistic regression was used to determine the influence of socioeconomic deprivation, as measured by the Area Deprivation Index, on language and developmental outcomes.
RESULTS: Greater socioeconomic deprivation significantly predicted poorer language outcomes in toddlers with CP ± L, including receptive vocabulary words (p = .02), expressive vocabulary words (p = .02), and late-developing gestures (p = .02). Additionally, toddlers from less affluent neighborhoods produced their first words significantly later than their counterparts living in more affluent areas (p < .01). Lower maternal education levels predicted significantly increased risk for problem solving delays (p < .01), and patients with subsidized insurance were at significantly increased risk for personal-social delays on the ASQ-3 (p < .01).
CONCLUSIONS: Children with CP ± L are susceptible to developmental delays associated with socioeconomic deprivation. These findings have implications for identifying a child's individual risk factors for developmental language disorders when conducting speech-language assessments. Future study should examine how inequities in care can be mitigated and addressed.
This is a prospective cohort study with randomized nested design. Patients presenting for shoulder surgery will be randomized to receive desflurane or total intravenous anesthesia with propofol. Regional cerebral oxygenation will be measured using the INVOS 5100C monitor (Covidien, Boulder, CO). Depth of anesthesia will be maintained within a Bispectral Index range of 40-60. Following positioning, inspired oxygen fraction and minute ventilation will be sequentially adjusted. At each set point, regional cerebral oxygenation will be recorded and venous blood gas analysis performed. Statistical analysis will be repeated measures analysis of variance in which ventilation strategy is the within-subjects factor and anesthetic technique is the between-subjects factor; post hoc Tukey's correction will be used for multiple comparisons. If simple maneuvers of ventilation and anesthetic technique can prevent low brain oxygen levels, patient outcome may be improved.
PROBLEM TO BE SOLVED: To provide an injectable aqueous ophthalmic composition and a method of use therefor.SOLUTION: The present invention is directed to the provision of an ophthalmic composition suitable for intravitreal injection. The composition includes an amount of complexing agent that reacts with one or more endogenous components (e.g., hyaluronic acid) in the eye to form a mass of enhanced viscosity. This mass can aid in creating a desirable release profile of therapeutic agent. The complexing agent is typically provided in an amount sufficient to form a mass of enhanced viscosity within a vitreous humor of an eye of a human upon injection of the composition into the human eye. The mass of enhanced viscosity will typically release the therapeutic agent by virtue of break down of the mass in the vitreous humor and/or the diffusion of the therapeutic agent out of the mass of enhanced viscosity. Advantageously, this allows release of the therapeutic agent over an extended period of time.
Stings from swarming hymenoptera such as bees, wasps, and ants can result in adverse reactions that are not due to anaphylactic shock. Instead, these reactions are mediated by biologically active molecules in the venom, such as enzymes and histamine-releasing peptides. Previously, there was no anti-venom or other pharmaceutical agent suitable for immediate treatment of hymenoptera stings. This disclosure provides a family of small-molecule sPLA2 inhibitors (including varespladib and AZD2716) that can serve this role. When administered orally or by injection shortly after the envenoming, these compounds prevent potentially lethal sequelae of the venom, such as acute kidney injury, hemolysis, and cerebral edema ù regardless of whether they can directly inhibit the type of sPLA2 that is in hymenoptera venom. AZD2176 is also effective in treating snake bites and scorpion stings. The sPLA2 inhibitors put forth in this disclosure represent life saving and organ sparing interventions for immediate treatment of envenomation in hospital settings and in the field.
The program development study will commence with a needs analysis, employing a democratic approach during the needs analysis process. An analysis of existing documents related to ethical education in nursing will be conducted. Studies on the current status and trends of ethical education in nursing in Turkey and worldwide, expert opinions, and a review of international and national documents will be examined to determine the direction of existing efforts. The Taba-Tyler program development model is planned for use in developing the education program. Based on the data obtained from the needs analysis, the education program will be prepared. Following the preparation of the Ethics Education Program, the population of the study consisting of second-year nursing students will be administered the Adapted Ethical Sensitivity Scale for Nursing Students, Nursing Ethical Dilemma Test, and Information Forms. Students who agree to participate will be informed about the research, and their consent will be obtained.

Thirty-four students who agreed to participate were included in the Nursing Ethics Education Program. They attended a 7-session training program, with each session lasting an average of 2 hours. At the conclusion of this training program, an evaluation of the program was conducted, and the second set of data was collected using the same data collection tools. Following a 1-month follow-up period and a 3-month follow-up period, the Adapted Ethical Sensitivity Scale for Nursing Students and the Nursing Ethical Dilemma Test were administered again to complete continuous measurements.
Compared to other malignancies, few studies have investigated the role of family history of cancer (FHC) in patients with lung cancer, yielding largely heterogeneous results. We performed a systematic literature review in accordance with PRISMA guidelines, searching the PubMed and Scopus databases from their inception to November 25, 2023, to identify studies reporting on the role of FHC in patients with lung cancer. A total of 53 articles were included, most with a retrospective design and encompassing a variety of geographical areas and ethnicities.Thirty studies (56.6%) assessed patients with non-small cell lung cancer (NSCLC), while 17 studies (32.1%) assessed patients with mixed histologies. Overall, the rates of FHC ranged from 8.3 to 68.9%, and the rates of family history of lung cancer ranged from 2 to 46.8%. Twenty-seven studies investigated FHC as a potential risk factor for lung cancer, with more than half reporting an increased risk for subjects with FHC. Five studies reported on the potential role of FHC in determining clinical outcomes, and twelve studies examined the relationship between FHC and germline mutations. Notably, only one study reported a significantly increased rate of germline mutations, including ATM, BRCA2, and TP53, for patients with a family history of lung cancer compared to those without, but both groups had a low prevalence of mutations (< 1%).The FAHIC-Lung (NCT06196424) is the first cross-sectional/prospective study specifically developed to identify FHC patterns and within-family clusters of other risk factors, including smoking, to guide patients with NSCLC to systematic genetic counseling. Acknowledging the largely heterogeneous results of our systematic review and considering the clinical implications of detecting pathogenic germline variants (PGVs), the FAHIC-lung study aims to identify patients potentially enriched with PGVs/likely PGVs to direct them to germline screening outside of the research setting.
Forensic pathologists are frequently asked to investigate cases of sudden death (SD), and identifying the cause of death can be of particular importance, especially where it may be necessary to perform family screening among the relatives of the victim. A multidisciplinary approach inclusive of genetic analysis is therefore strongly recommended. According to forensic practice, arrhythmogenic cardiomyopathy (ACM) is a well-known cause of SD. However, cases of SD caused by a left ventricular pattern of ACM diagnosed at autopsy are rarely reported in the literature. We present the case of an apparently healthy, 37-year-old male found dead at his home. At autopsy, multiple foci of epicardial and mid-wall fibrous and fibro-adipose tissue were observed within the left ventricle and, to a lesser extent, within the interventricular septum. Toxicology was negative, whereas a filamin C truncating mutation was detected through genetic analysis. To our knowledge, this is the first instance of arrhythmogenic left ventricular cardiomyopathy being diagnosed at autopsy.
PURPOSE:To obtain the titled hemagglutinin in high purity, by bringing a culture of a mold belonging to the genus Bordetella into contact with cellulose sulfuric ester gel, adsorbing filamentous Hemagglutinin on the gel, eluting it from the gel. CONSTITUTION:A solution containing filamentous hemagglutinin (F-HA) produced from a mold belonging to the genus Bordetella is brought into contact with gel of cellulose sulfuric ester (sulfuric ester of a crystalline cellulose or a cellulose consisting of crystalline range and noncrystalline range, etc.). In the operation, the gel is previously adjusted to pH value (6-9pH) near neutrality, and equilibrated by the use of a proper buffer solution having 5-25ms/cm specific conductivity. Then, F-HA is adsorbed on F-HA. The adsorbed F-HA is eluted from the gel by the use of a buffer solution having 5-10pH and 25-130ms/cm specific conductivity, purified and collected. It contains no protein, lipoid, saccharide, etc., an endotoxin is almost completely removed from it, and F-HA is useful for preparing various reagents, etc. and pertussis vaccine.
Cervical cancer is the fourth most common cancer among women globally. The detrimental health effects of estrogenic endocrine disruptors (EED), such as bisphenol A (BPA) and phthalates, are recognized, but their role in cervical cancer progression remains unclear. To investigate this, a transcriptome analysis using bioinformatics was conducted. The Comparative Toxicogenomics Database (CTD) identified estrogen-responsive genes (ERGs) associated with EED. Cervical cancer expression and clinical data were sourced from The Cancer Genome Atlas (TCGA). The limma package identified differentially expressed ERGs (DERGs), which were further analyzed for molecular mechanisms through enrichment analysis. LASSO regression developed a prognostic risk score model, and COX analysis identified prognostic biomarkers. ssGSEA assessed immune tumor infiltration, and Autodock performed molecular docking. A total of 217 DERGs were linked to endocrine resistance, estrogen signaling, and the cell cycle. The prognostic risk score and nomogram based on DERGs were highly predictive of cervical cancer prognosis and could serve as independent risk factors. The risk score influenced the tumor immune microenvironment by affecting immune cell presence. SCARA3 and FASN emerged as independent prognostic factors, with molecular docking confirming strong binding between EED and FASN. DERGs can aid in creating a reliable prognostic model and predicting overall survival in cervical cancer patients, offering new insights into the impact of EED on cancer progression and highlighting environmental factors related to cancer risks and development.
We sought to investigate the effects of fast-track rehabilitation nursing on pressure ulcers, length of hospital stay and postoperative complications in patients with inter-trochanteric fractures (ITF). The PubMed, Web of Science, Embase, Cochrane Library, China National Knowledge Infrastructure and WanFang databases were searched for randomised controlled trials (RCTs) published from inception to September 2023 on the application of fast-track rehabilitative nursing to ITF. Two investigators independently screened the literature and performed data extraction and quality assessments using the Cochrane Risk of Bias Assessment Tool. The meta-analysis was performed using RevMan 5.4. Overall, 22 RCTs involving 1904 patients were included. Meta-analysis revealed that after fast-track rehabilitation nursing intervention in patients with ITF, the occurrence of pressure ulcers (odds ratio [OR]: 0.29; 95% confidence interval [CI]: 0.18-0.47; p < 0.001) and postoperative complications (OR: 0.19; 95% CI: 0.14-0.26; p < 0.001) were significantly reduced and hospital stay was significantly shorter (standardised mean difference: -3.10; 95% CI: -3.82 to -2.38; p < 0.001). Nursing care for patients with ITF based on the concept of fast-track rehabilitation is conducive to reducing the occurrence of pressure ulcers, lowering the occurrence of complications, shortening the length of hospitalisation and promoting postoperative rehabilitation.
OBJECTIVE: This study investigated whether short-term incremental prednisone therapy decreases the risk of relapse without increasing adverse events (AEs) in patients with serologically active, clinically quiescent lupus nephritis (LN).
METHODS: After standardized treatment, 153 patients with serologically active, clinically quiescent LN were included. Clinical data were retrospectively reviewed. The patients were divided into two groups: the control group (n = 58) received prednisone or prednisone and immunosuppressant maintenance therapy, the prednisone increment group (n = 95) received additional prednisone doses of up to 10 mg/day as maintenance therapy, which were then gradually reduced back to the original dose at 3 months. Lupus activity, renal involvement, and AEs during follow-up in the two groups were analyzed within 18 months.
RESULTS: No significant differences in sex, age, disease course, maintenance treatment composition, or laboratory tests between the two groups were observed, except for serum complement C3 levels, which were significantly lower in patients in the prednisone increment group than in controls (P = 0.025). The prednisone increment group had significantly lower recurrence rates than the control group (P = 0.002), with only 3 patients (5.2%) in the prednisone increment group and 24 patients (25.3%) in the control group experiencing relapse. Renal recurrence was significantly lower in the prednisone increase group (P = 0.013). Nine AEs occurred in the prednisone-modulated group and 11 AEs occurred in controls, with infection being the main cause for both groups.
CONCLUSION: Short-term incremental prednisone therapy is safe in reducing recurrence rates in serologically active and clinically quiescent patients with LN. Key points Incremental prednisone is safe and effective for patients with serologically active clinically quiescent LN.
Clinical hepatitis and hepatic decompensation, including some fatalities, were reported with APTIVUS co-administered with 200 mg of ritonavir. These have generally occurred in subjects with advanced HIV-1 disease taking multiple concomitant medications. A causal relationship to APTIVUS/ritonavir could not be established. Physicians and patients should be vigilant for the appearance of signs or symptoms of hepatitis, such as fatigue, malaise, anorexia, nausea, jaundice, bilirubinuria, acholic stools, liver tenderness or hepatomegaly. Patients with signs or symptoms of clinical hepatitis should discontinue APTIVUS/ritonavir treatment and seek medical evaluation.

All patients should be followed closely with clinical and laboratory monitoring, especially those with chronic hepatitis B or C co-infection, as these patients have an increased risk of hepatotoxicity. Liver function tests should be performed prior to initiating therapy with APTIVUS/ritonavir, and frequently throughout the duration of treatment.

If asymptomatic elevations in AST or ALT greater than 10 times the upper limit of normal occur, APTIVUS/ritonavir therapy should be discontinued. If asymptomatic elevations in AST or ALT between 5 – 10 times the upper limit of normal and increases in total bilirubin greater than 2.5 times the upper limit of normal occur, APTIVUS/ritonavir therapy should be discontinued.

Treatment-experienced patients with chronic hepatitis B or hepatitis C co-infection or elevated transaminases are at approximately 2-fold risk for developing Grade 3 or 4 transaminase elevations or hepatic decompensation. In two large, randomized, open-label, controlled clinical trials with an active comparator (1182.12 and 1182.48) of treatment-experienced subjects, Grade 3 and 4 increases in hepatic transaminases were observed in 10.3% (10.9/100 PEY) receiving APTIVUS/ritonavir through week 48. In a study of treatment-naïve subjects, 20.3% (21/100 PEY) experienced Grade 3 or 4 hepatic transaminase elevations while receiving APTIVUS/ritonavir 500 mg/200 mg through week 48.

Tipranavir is principally metabolized by the liver. Caution should be exercised when administering APTIVUS/ritonavir to patients with mild hepatic impairment (Child-Pugh Class A) because tipranavir concentrations may be increased [see Clinical Pharmacology (12.3)].
Innovaderm, in collaboration with "The Immunoregulation laboratories of CRCHUM" and "McGill University division of dermatology", recently developed a novel 6-hour method to study IL-17A (Interleukin) and IL-22 from fresh biopsies of psoriatic patients. This reproducible experimental approach combines enzymatic digestion and mechanical dissociation for skin cell isolation. This is followed by a multi-color flow cytometry analysis in the absence of in vitro expansion and re-stimulation. Using this method, we examined the cellular source of IL-17A and IL-22 on a small number (20x10³) of viable CD45+ (Cluster of Differentiation Antigen 45) cells that are freshly isolated from 4 mm punch skin biopsies (n=22 patients with psoriasis). The method was used for the study on "Persistence of IL-17A+ T lymphocytes and IL-17A expression in psoriatic plaques refractory to ustekinumab therapy" presented during the 72nd annual meeting of the American Academy of Dermatology in Denver. A detailed presentation of this method will be done during the upcoming annual meeting of the Society for Investigative Dermatology in Albuquerque, New Mexico.

We would like to investigate and adapt this method for other dermatological conditions such as Atopic Dermatitis, Acne Rosacea and Acne Vulgaris.